Literature DB >> 3311108

Circulating lymphoma cells in patients with B & T non-Hodgkin's lymphoma detected by immunoglobulin and T-cell receptor gene rearrangement.

M Brada1, S Mizutani, H Molgaard, J P Sloane, J Treleaven, A Horwich, M J Peckham.   

Abstract

We studied peripheral blood mononuclear cells from 50 patients with active B- and T-cell non-Hodgkin's lymphoma by DNA hybridisation. Nineteen patients (38%) had circulating clones of cells detected by immunoglobulin gene rearrangement (17 patients) or T-cell receptor gene rearrangement (2 patients) with JH and J beta 2 probes. Lymphoma tissue and peripheral blood were studied simultaneously in 22 patients, 9 of which had a circulating clone of cells in peripheral blood. In 7 patients the gene rearrangement in lymphoma tissue and peripheral blood mononuclear cells was identical. However, in 2 patients both heavy chain and light chain gene rearrangements were different in tissue and peripheral blood. The incidence of peripheral blood involvement was commonest in advanced CSIII & IV disease (54%) compared to CSI & II disease (18%) (P less than 0.05), and in low grade (45%) compared to intermediate and high grade lymphoma (31%) (difference not statistically significant). Only 4 patients had definite lymphoma cells seen on peripheral blood smear. The presence of circulating lymphoma cells correlated with conventional assessment of bone marrow involvement although circulating clones were detected in 30% (12/40) of patients with apparently normal bone marrow.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311108      PMCID: PMC2002151          DOI: 10.1038/bjc.1987.174

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  32 in total

1.  Incidence cytology, and histopathology of non-Hodgkin's lymphomas in the bone marrow.

Authors:  F Dick; C D Bloomfield; R D Brunning
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

2.  Report of the Committee on Hodgkin's Disease Staging Classification.

Authors:  P P Carbone; H S Kaplan; K Musshoff; D W Smithers; M Tubiana
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

3.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  Follicular lymphomas: possibility that they are benign tumors of the lymphoid system.

Authors:  E S Jaffe
Journal:  J Natl Cancer Inst       Date:  1983-03       Impact factor: 13.506

5.  Detection of tumor cells in the peripheral blood of nonleukemic patients with B-cell lymphoma: analysis of "clonal excess".

Authors:  F S Ligler; R G Smith; J R Kettman; J A Hernandez; J B Himes; E S Vitetta; J W Uhr; E P Frenkel
Journal:  Blood       Date:  1980-05       Impact factor: 22.113

6.  Nodular lymphoma: bone marrow and blood manifestations.

Authors:  R W McKenna; C D Bloomfield; R D Brunning
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

7.  Initial chemotherapy for clinically localized lymphomas of unfavorable histology.

Authors:  T P Miller; S E Jones
Journal:  Blood       Date:  1983-08       Impact factor: 22.113

8.  Non-Hodgkin's lymphomas in leukemic phase: clinicopathologic correlations.

Authors:  S E Come; E S Jaffe; J C Andersen; R B Mann; B L Johnson; V T DeVita; R C Young
Journal:  Am J Med       Date:  1980-11       Impact factor: 4.965

9.  Abnormal peripheral blood lymphocytes and bone marrow infiltration in non-Hodgkin's lymphoma.

Authors:  J V Garrett; J H Scarffe; R K Newton
Journal:  Br J Haematol       Date:  1979-05       Impact factor: 6.998

10.  Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging.

Authors:  R Bartl; B Frisch; R Burkhardt; G Kettner; G Mahl; A Fateh-Moghadam; M Sund
Journal:  Br J Haematol       Date:  1982-08       Impact factor: 6.998

View more
  6 in total

Review 1.  Molecular biology in medicine.

Authors:  B D Young
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

2.  Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma.

Authors:  S K Juneja; M M Wolf; I A Cooper
Journal:  J Clin Pathol       Date:  1990-08       Impact factor: 3.411

3.  Clonality of T cell and phenotypically undefined lymphoid neoplasms: the value of genotypic analyses.

Authors:  E Hodges; G N Stacey; W M Howell; D B Jones; J L Smith
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

4.  Assessment of bone marrow infiltration in B-cell non-Hodgkin's lymphoma (NHL).

Authors:  E L Dorey; S V Outram; A Holder; A Z Rohatiner; F E Cotter; M Deane; A G Stansfeld; T A Lister; M A Horton
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

5.  Peripheral blood involvement in non-Hodgkin's lymphoma detected by clonal gene rearrangement as a biological prognostic marker.

Authors:  L R Hiorns; J Nicholls; J P Sloane; A Horwich; S Ashley; M Brada
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

6.  2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.

Authors:  Yingxi Xu; Qian Liu; Mengjun Zhong; Zhenzhen Wang; Zhaoqi Chen; Yu Zhang; Haiyan Xing; Zheng Tian; Kejing Tang; Xiaolong Liao; Qing Rao; Min Wang; Jianxiang Wang
Journal:  J Hematol Oncol       Date:  2019-05-16       Impact factor: 17.388

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.